Acrophyte Hospitality Trust (SGX:XZL) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


SGX:XZL Acrophyte Hospitality Trust SGX:XZL
40 GF Score
Price $0.21
GF Value $0.26
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Acrophyte Hospitality Trust Research & Development?

Acrophyte Hospitality Trust SGX:XZL -2.33% 40 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates SGX:XZL with a GF Score™ of 40/100 and a GF Value™ of $0.26 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Acrophyte Hospitality Trust's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Acrophyte Hospitality Trust  (SGX:XZL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Acrophyte Hospitality Trust Research & Development Related Terms

Acrophyte Hospitality Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Acrophyte Hospitality Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acrophyte Hospitality Trust Research & Development Chart

Acrophyte Hospitality Trust Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Acrophyte Hospitality Trust Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SGX:XZL
40GF Score
Acrophyte Hospitality Trust SGX:XZL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acrophyte Hospitality Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Acrophyte Hospitality Trust (SGX:XZL) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Acrophyte Hospitality Trust and its competitors.
Is Acrophyte Hospitality Trust's Research & Development too high?
Acrophyte Hospitality Trust's current Research & Development is $0.0 Mil. Overall, Acrophyte Hospitality Trust has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acrophyte Hospitality Trust's Research & Development compare to HST and RHP?
Acrophyte Hospitality Trust's Research & Development of $0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Acrophyte Hospitality Trust and its competitors. Acrophyte Hospitality Trust's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acrophyte Hospitality Trust stock overvalued right now?
Based on GuruFocus' analysis, Acrophyte Hospitality Trust (SGX:XZL) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.26, compared to a current price of $0.21 — trading 19.2% below its estimated fair value. The current Research & Development is $0.0 Mil. Acrophyte Hospitality Trust's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Acrophyte Hospitality Trust (SGX:XZL), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acrophyte Hospitality Trust (SGX:XZL) Overvalued in 2026?

Based on GuruFocus' analysis, Acrophyte Hospitality Trust stock appears to be undervalued. The current stock price of $0.21 is trading 19.2% below its estimated GF Value™ of $0.26. GuruFocus considers Acrophyte Hospitality Trust to be Modestly Undervalued.

Key valuation signals for SGX:XZL:

  • Research & Development: $0.0 Mil
  • GF Value™: $0.26 vs. price of $0.21 (19.2% below fair value)
  • GF Score™: 40/100 with 7 warning signs

No single metric tells the full story. See the SGX:XZL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acrophyte Hospitality Trust Business Description

Industry Real EstateREITs
Address 10 Anson Road, No. 23-15, International Plaza, Singapore, SGP, 079903
Acrophyte Hospitality Trust invests in a portfolio of income-producing real estate, which is used mainly for hospitality and hospitality-related purposes, located in the United States of America, along with real estate-related assets connected to these operations. The trust offers investors the opportunity to invest in the upscale-select service hospitality sector in key U.S. growth regions. The various hotel brands in its investment portfolio include Hyatt House, Hyatt Place, AC Hotels by Marriott, Courtyard by Marriott, Residence Inn by Marriott, and Home2 Suites by Hilton. The trust's reportable segments include Hyatt, which generates the maximum revenue, Marriott, and Hilton.
40GF Score

Get the complete analysis for SGX:XZL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price
$0.26
GF Value